| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $528K | +51.7% |
| SG&A Expense | $14.0M | +100.3% |
| Operating Income | $6.0M | +391.8% |
| Pre-tax Income | -$7.6M | -29.1% |
| Income Tax | $128K | — |
| Net Income | -$7.0M | -31.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.1M | +23.4% |
| Total Assets | $43.0M | +67.3% |
| Total Liabilities | $5.7M | +118.6% |
| Stockholders' Equity | $37.3M | +64.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | -9.0% |
| Capital Expenditures | $439K | +127.1% |
| Investing Cash Flow | -$8.2M | +50.0% |
| Financing Cash Flow | $17.8M | -18.1% |
| Free Cash Flow | -$7.6M | -12.3% |